Please login to the form below

Not currently logged in
Email:
Password:

Roche nominates Dr Claudia Süssmuth Dyckerhoff to board

She is set to replace Professor Dr Beatrice Weder di Mauro

Roche - Basel, SwitzerlandRoche's board of directors have lined up Dr Claudia Süssmuth Dyckerhoff to replace Professor Dr Beatrice Weder di Mauro, who has decided to not stand for re-election at the company's annual general meeting in March.

Weder di Mauro has been a member of the board since 2006 and also served on its audit committee.

Dyckerhoff is currently senior partner at McKinsey & Company and sector leader Asia health services and systems.

Christoph Franz, chairman of Roche, said: “As a member of the board and the audit committee, Beatrice Weder di Mauro has made significant contributions to Roche's success with her broad expertise in economics.”

He added: “I am delighted with our nomination of Claudia Süssmuth Dyckerhoff for election as a new member of the board. She is a leader with extensive international experience in strategic consultancy in the healthcare industry, especially in Asian growth markets.”

7th January 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
SEVEN STONES

Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....

Latest intelligence

CBC
Building Europe’s next breakthrough biotechs
Start Codon's Daniel Rooke on fostering biotech success in Cambridge, UK...
Tactful screening & participant sensitivity
Screening participants can involve asking personal questions that could be perceived as intrusive. Here CMR explores the implications of such lines of questioning....
Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...

Infographics